Jennison Associates
IFRX icon

Jennison Associates’s InflaRx IFRX Stock Holding History

Jennison Associates’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-64,368
Closed -$1.86M – 677
2018
Q1 		$1.86M Sell
64,368
-137,938
-68% -$3.64M ﹤0.01% 527
2017
Q4 		$4.24M Buy
+202,306
New +$3.65M ﹤0.01% 503

Other funds holding IFRX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jennison Associates's IFRX Position: Q2 2018 in Review

Jennison Associates sold out of InflaRx (IFRX) in Q2 2018, closing a stake of 64,368 shares — an estimated $1.86M sold.

Jennison Associates first reported a position in IFRX in Q4 2017 and held it in 2 quarters. The position peaked at $4.24M in Q4 2017. 34 funds tracked by Wall St. Rank hold IFRX as of Q2 2018.

  • Jennison Associates reported no remaining InflaRx position as of Q2 2018 after selling out during the quarter.
  • Jennison Associates sold 64,368 InflaRx shares in Q2 2018, an estimated $1.86M.
  • Jennison Associates first reported a position in InflaRx in Q4 2017 and held it in 2 quarters.
  • Jennison Associates's InflaRx position peaked at $4.24M in Q4 2017.
  • 34 funds tracked by Wall St. Rank held InflaRx as of Q2 2018.

Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.